CN111235089A - 一种细胞纯悬浮工艺生产猪圆环病毒2型(pcv2)的方法 - Google Patents
一种细胞纯悬浮工艺生产猪圆环病毒2型(pcv2)的方法 Download PDFInfo
- Publication number
- CN111235089A CN111235089A CN201811441233.XA CN201811441233A CN111235089A CN 111235089 A CN111235089 A CN 111235089A CN 201811441233 A CN201811441233 A CN 201811441233A CN 111235089 A CN111235089 A CN 111235089A
- Authority
- CN
- China
- Prior art keywords
- cells
- culture
- cell
- virus
- bioreactor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 241001673669 Porcine circovirus 2 Species 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 230000008569 process Effects 0.000 title claims abstract description 7
- 239000000725 suspension Substances 0.000 title claims description 8
- 241000700605 Viruses Species 0.000 claims abstract description 25
- 230000003321 amplification Effects 0.000 claims abstract description 16
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 16
- 238000003306 harvesting Methods 0.000 claims abstract description 13
- 238000004114 suspension culture Methods 0.000 claims abstract description 12
- 239000001963 growth medium Substances 0.000 claims abstract description 11
- 238000012258 culturing Methods 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 6
- 239000001301 oxygen Substances 0.000 claims abstract description 6
- 239000005723 virus inoculator Substances 0.000 claims abstract description 5
- 238000009423 ventilation Methods 0.000 claims description 18
- 238000011081 inoculation Methods 0.000 claims description 16
- 230000003833 cell viability Effects 0.000 claims description 12
- 238000004113 cell culture Methods 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 4
- 101100533323 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SFM1 gene Proteins 0.000 claims 1
- 210000002966 serum Anatomy 0.000 abstract description 5
- 239000006285 cell suspension Substances 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 83
- 238000010790 dilution Methods 0.000 description 21
- 239000012895 dilution Substances 0.000 description 21
- 239000007788 liquid Substances 0.000 description 13
- 238000002156 mixing Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 238000012423 maintenance Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 239000013641 positive control Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000005273 aeration Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 241000282898 Sus scrofa Species 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- -1 100 μ L per well Substances 0.000 description 2
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241001533384 Circovirus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811441233.XA CN111235089A (zh) | 2018-11-28 | 2018-11-28 | 一种细胞纯悬浮工艺生产猪圆环病毒2型(pcv2)的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811441233.XA CN111235089A (zh) | 2018-11-28 | 2018-11-28 | 一种细胞纯悬浮工艺生产猪圆环病毒2型(pcv2)的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111235089A true CN111235089A (zh) | 2020-06-05 |
Family
ID=70875761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811441233.XA Pending CN111235089A (zh) | 2018-11-28 | 2018-11-28 | 一种细胞纯悬浮工艺生产猪圆环病毒2型(pcv2)的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111235089A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160333322A1 (en) * | 2015-05-14 | 2016-11-17 | Merial Inc. | Method for porcine circovirus production and pcv2 vaccines |
CN107312746A (zh) * | 2017-06-22 | 2017-11-03 | 中国农业科学院哈尔滨兽医研究所 | 一种猪圆环病毒2型的大规模全悬浮培养方法 |
CN108570445A (zh) * | 2017-11-09 | 2018-09-25 | 甘肃健顺生物科技有限公司 | Pk15细胞驯化悬浮方法和二阶病毒生产工艺 |
-
2018
- 2018-11-28 CN CN201811441233.XA patent/CN111235089A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160333322A1 (en) * | 2015-05-14 | 2016-11-17 | Merial Inc. | Method for porcine circovirus production and pcv2 vaccines |
CN107312746A (zh) * | 2017-06-22 | 2017-11-03 | 中国农业科学院哈尔滨兽医研究所 | 一种猪圆环病毒2型的大规模全悬浮培养方法 |
CN108570445A (zh) * | 2017-11-09 | 2018-09-25 | 甘肃健顺生物科技有限公司 | Pk15细胞驯化悬浮方法和二阶病毒生产工艺 |
Non-Patent Citations (1)
Title |
---|
刘明华 等, 武汉理工大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107312746B (zh) | 一种猪圆环病毒2型的大规模全悬浮培养方法 | |
CN107201333B (zh) | 可悬浮培养的牛肾细胞在病毒培养及疫苗生产的应用 | |
CN107460156B (zh) | 无血清全悬浮mdck细胞株及其在生产流感病毒中的应用 | |
CN103952379A (zh) | 重组猪伪狂犬病毒毒株及其制备方法 | |
CN106085946A (zh) | 可以悬浮培养的猪睾丸细胞株st‑s及其获得方法与应用 | |
CN107267443A (zh) | 一种适应全悬浮培养的vero E6细胞株及其应用 | |
CN109913404A (zh) | 鸡传染性法氏囊病毒活疫苗的制备方法 | |
CN113564127A (zh) | 一种大规模悬浮培养禽腺病毒的方法 | |
CN111676185A (zh) | 一种全悬浮培养型mdck细胞系的驯化方法 | |
CN104894054B (zh) | 一种猴胚胎肾上皮细胞Marc‑145悬浮适应株及其在培养蓝耳病病毒、生产蓝耳病毒疫苗中的应用 | |
CN111235089A (zh) | 一种细胞纯悬浮工艺生产猪圆环病毒2型(pcv2)的方法 | |
CN109536437B (zh) | 一种维持稳定性、高滴度病毒抗原生产的悬浮细胞病毒的培养方法 | |
CN116515728A (zh) | 无弹状病毒的Sf9-PT细胞及其应用 | |
CN112680422A (zh) | 一种全悬浮无血清mdck细胞增殖h9n2亚型禽流感病毒的方法 | |
CN106237324B (zh) | 一种使用全悬浮技术生产猪传染性胃肠炎疫苗的方法 | |
CN114989269A (zh) | 一种牛赤羽免疫原性抗原及疫苗 | |
CN109679900B (zh) | 禽流感疫苗的制备方法及其产品 | |
CN109280648B (zh) | 一种制备水貂细小病毒性肠炎抗原蛋白复合物的方法、抗原蛋白复合物及其应用 | |
CN107723279B (zh) | 一种缺陷型腺病毒AdC68-GP的培养方法 | |
CN110669739A (zh) | 一种新型甲型肝炎病毒抗原制备方法 | |
CN107475205B (zh) | 一种猪圆环病毒分离方法 | |
CN106754747B (zh) | 新的猪圆环病毒及其共培养细胞株 | |
CN110862972B (zh) | 一种犬腺病毒ⅰ型无血清培养方法 | |
CN114891718B (zh) | 用于悬浮培养骨髓细胞的培养基、制备方法、应用和诱导骨髓源细胞分化为巨噬细胞的方法 | |
CN113444693B (zh) | 一种噬菌体与益生菌的联合发酵工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant after: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: CHENGDU TECBOND BIOLOGICAL PRODUCTS CO.,LTD. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221208 Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200605 |